ข่าวประชาสัมพันธ์ Press Releases ข่าวย้อนหลัง หัวข้อข่าว บลอก

วันศุกร์ที่ ๓๐ กันยายน พ.ศ. ๒๕๕๙ ๐๓:๒๓ น.

Food and Healthcare Press Releases

PReMA Aims to Drive Good Governance in Thailand#s Public Health and Drug System Heathcare—๒๘ ก.ย. ๕๙

The Pharmaceutical Research and Manufacturers Association (PReMA) Aims to Drive Good Governance in Thailand's Public Health and Drug System The Pharmaceutical Research and Manufacturers Association (PReMA) is staging a multi-stakeholder forum on "Good

A Third of People Track Their Health or Fitness. Who Are They and Why Are They Doing it? Heathcare—๒๙ ก.ย. ๕๙

NUREMBERG, Germany--29 Sep--PRNewswire/InfoQuest

A recent international GfK survey , conducted online in 16 countries, shows one in three people (33 percent) currently monitor or track their health or fitness via an online or mobile application, or via a fitness band, clip, or smartwatch.

China is well in the lead for monitoring health and fitness in this way, with 45 percent of the online population currently doing this. Brazil and the USA come next, with 29 percent each, closely followed by Germany (28 percent) and France (26 percent).

In most countries studied, men are ahead of women in this activity, but five countries stand out as having a higher percentage of their female than their male online population currently tracking their health and fitness in this way: China (48 percent of women, compared to 43 percent of the men), Russia (21 percent of women and 17 percent of men), France (27 percent and 25 percent), Australia (20 percent and 18 percent), and Canada (20 percent and 19 percent).

Looking at age, it is those aged 30-39 and 20-29 years old that are most keen on tracking their health and fitness - standing at 41 percent and 39 percent of each age group respectively. However, teenagers (15-19 year olds) and the 20-29 year olds both show almost a quarter of their numbers saying that, while they do not curren

Take Action This World Heart Day Heathcare—๒๙ ก.ย. ๕๙

This World Heart Day (29 September 2016), the World Heart Federation (WHF) is urging people around the globe to use the power of information to transform the 1 in 10 lives that are being cut short prematurely as a direct result of cardiovascular disease

Protect Your Flexible Scope: New Dornier GentleFlex(R) Holmium Laser Fiber Delivers the Confidence Heathcare—๒๘ ก.ย. ๕๙

Dornier MedTech(R), a global medical device company, introduced their latest innovation in laser lithotripsy. Known as the Dornier GentleFlex(R), this is a specially-designed ball tip fiber. The Dornier GentleFlex(R) smooths the passage of the laser

Merck KGaA, Darmstadt, Germany to Present New Research Focused on Hard-to-Treat Cancers at ESMO Heathcare—๒๘ ก.ย. ๕๙

ESMO Abstract # Avelumab: 777PD, 7775PD, 1154P, 842TiP, 844TiP; Erbitux: 527P, 491P, 967P, 994P; Tepotinib: 1257P, 1287TiP, 1292TiP - Merck KGaA, Darmstadt, Germany, to feature new research from marketed and pipeline compounds - Preliminary results from

Merck to Present New Research Focused on Hard-to-Treat Cancers at ESMO Heathcare—๒๘ ก.ย. ๕๙

Avelumab: 777PD, 775PD, 1154P, 842TiP, 844TiP; Erbitux: 527P, 491P, 967P, 994P; Tepotinib: 1257P, 1287TiP, 1292TiP - Merck to feature new research from marketed and pipeline compounds - Preliminary results from combination study with avelumab in renal

Asia Plantation Capital#s Science Team Researches Oud Oil in Cancer Heathcare—๒๘ ก.ย. ๕๙

For thousands of years, agarwood, and the Oud oil derived from it, have been revered by a plethora of cultures and religions. Having become an essential aspect of the cultural and religious life for billions of people, scientific research is now

OGT Simplifies Detection of Important Cancer Gene Variants Heathcare—๒๗ ก.ย. ๕๙

Oxford Gene Technology (OGT), The Molecular Genetics Company, has launched its SureSeq myPanel(TM) NGS Custom Cancer Panels to provide scientists with completely customised, pre-optimised next generation sequencing (NGS) probe panels relevant to their

New Report Calls for Fresh Approach to Treating Worlds No. 1 Killer Heathcare—๒๗ ก.ย. ๕๙

A major review is calling for improvements in the way hypertension is treated on a global scale. The Lancet Commission on Hypertension cites 'unsolved areas' that if tackled could help reduce the burden of high blood pressure, the world's number one

World Heart Federation Urges Governments to Act Now on Cardiovascular Heathcare—๒๓ ก.ย. ๕๙

One week ahead of World Heart Day on 29 September, World Heart Federation calls on governments to increase efforts to prevent cardiovascular disease (CVD) epidemic The World Heart Federation (WHF) is today issuing a global policy call to governments to

Merck and the Royal Health Awareness Society Partner to Advance Women#s Health in Heathcare—๒๓ ก.ย. ๕๙

- New partnership under Healthy Women, Healthy Economies initiative facilitates women to overcome health barriers to economic participation Merck, a leading science and technology company, today announced its partnership with the Royal Health Awareness

Thailand LAB INTERNATIONAL 2016 expecting 3,000 million baht transaction Heathcare—๒๒ ก.ย. ๕๙

Associate Professor Dr. Weerapong Paesuwan, Permanent Secretary for the Ministry of Science and Technology said that Thailand LAB INTERNATIONAL 2016 is the largest international trade exhibition and conference on Analytical Laboratory, Equipment and

New digital health solutions to boost care quality in emerging markets Heathcare—๒๑ ก.ย. ๕๙

New digital healthcare models based on cloud solutions and open-source medical record systems will make healthcare access, quality, and safety more affordable, according to a PwC study. The Digital Healthcare Leap says that while Traditional Electronic

Amatara signs agreement with Bangkok Airways and Bangkok Hospital Phuket Heathcare—๒๑ ก.ย. ๕๙

Amatara signs agreement with Bangkok Airways and Bangkok Hospital Phuket to offer the first ever-integrated tourism & health services in the region Amatara Wellness Resort, one of Southeast Asia's premier wellness resort & spa destinations, has

Jubilant Biosys Strengthens its Leadership Team With Two Key Appointments Heathcare—๒๐ ก.ย. ๕๙

Jubilant Biosys Ltd (Jubilant Biosys), a leader in collaborative drug discovery , announced two new leadership appointments. Mr. Steven Hutchins has been appointed as President and Dr. Takeshi Yura has been appointed as Vice President of Medicinal

Semaglutide reduced major cardiovascular events by 26% in adults with type 2 diabetes at high Heathcare—๑๖ ก.ย. ๕๙

Novo Nordisk today announced that semaglutide, an investigational glucagon-like peptide-1 (GLP-1) analogue administered once-weekly, significantly reduced the risk of the primary composite endpoint of time to first occurrence of either cardiovascular

Victoza(R) lowered the progression of kidney damage in adults with type 2 diabetes at high CV Heathcare—๑๖ ก.ย. ๕๙

Novo Nordisk today announced that the progression of kidney damage was significantly lower with Victoza(R) treatment vs placebo, as measured by urinary albumin creatinine ratio, both added to standard of care in 9,340 adults with type 2 diabetes at high

Merck Joins DiViNe Consortium to Address Low Yields, High Costs of Vaccine Purification Heathcare—๑๕ ก.ย. ๕๙

Merck , a leading science and technology company, has joined the DiViNe project , a European consortium of six companies to address the biggest challenges facing the development, manufacture and delivery of vaccines. Photo -

Saxenda(R) Provides Consistent Weight Loss and Improvements in Blood Glucose Control Across BMI Heathcare—๑๔ ก.ย. ๕๙

Results from a post hoc analysis of the three-year part of the phase 3a SCALE (Satiety and Clinical Adiposity - Liraglutide Evidence) Obesity and Prediabetes trial show that people treated with Saxenda(R) (liraglutide 3 mg) experienced consistent weight

Semaglutide Demonstrated Superior HbA1c Reduction vs Placebo as Add-on to Basal Insulin Alone or Heathcare—๑๓ ก.ย. ๕๙

Novo Nordisk today announced that semaglutide, an investigational glucagon-like peptide-1 (GLP-1) analogue administered once-weekly, significantly improved glycaemic control compared to placebo, as add-on to basal insulin alone or in combination with

Adults with Type 2 Diabetes Treated with Xultophy(R) (IDegLira) were up to 4.5 Times More Likely to Heathcare—๑๓ ก.ย. ๕๙

Novo Nordisk today presented data showing the odds of reaching fasting plasma glucose (FPG) targets without hypoglycaemia and weight gain were significantly greater for Xultophy(R) (IDegLira) compared to up-titration with insulin glargine U100 in adults

OGT Expands Cytocell FISH Probe Portfolio for Lung Cancers Heathcare—๑๓ ก.ย. ๕๙

Oxford Gene Technology (OGT), The Molecular Genetics Company, has launched two new CE-IVD labelled fluorescence in situ hybridisation (FISH) probes, further expanding its extensive lung cancer portfolio. The Cytocell Aquarius(R) ROS1 Plus Breakapart and

Merck#s Consumer Health Business Presents New Purpose to Help Prepare Society for 100 Healthy Heathcare—๑๓ ก.ย. ๕๙

- "WE100" movement will promote activities to prepare society for 100 healthy years across generations Merck, a leading science and technology company, revealed the new purpose "Prepare society for a new era of humans living 100 healthy years" for its

Merck Announces Recipients of the Grant for Growth Innovation 2016 Heathcare—๑๒ ก.ย. ๕๙

- The presentation of the grants coincides with the 55th European Society for Paediatric Endocrinology (ESPE) Meeting - The awards support innovative projects for the advancement of science and medical research in the field of growth Merck, a leading